Leadership

Reprise is led by experienced medical device commercialization management team with a record of success in biologic medical devices and guided by a Board of Directors with proven track records for success.

Our Approach

Through an innovative and clinically focused approach, we strive to bring solutions to the unmet clinical needs of surgeons which result in positive clinical outcomes for patients.

Management Team

Carrie Powers

President and Chief Executive Officer

Ms. Powers has served as President and Chief Executive Officer of Reprise since May 2019. From 2006 through February 2018, Ms. Powers held a succession of positions of increasing responsibility at Vascular Solutions, Inc., starting as Associate Product Manager in 2006 and rising to Senior Vice President of Marketing at the time of the company’s acquisition by Teleflex Incorporated in 2017. Following that acquisition, Ms. Powers continued in management at Teleflex in the role of Senior Director of Clinical & Medical Affairs. From March 2018 to February 2019, Ms. Powers served on the management team of the medical device company CHF Solutions, Inc., first as its Vice President of Marketing and most recently as its Senior Vice President of Commercial Operations. Prior to joining Vascular Solutions, Ms. Powers was employed by St. Mary’s Hospital in Madison, Wisconsin from 2002 to 2006, most recently as a Registered Nurse in the Interventional Cardiac Catheterization Lab.

Hale Ichinose

Vice President of Quality

Mr. Ichinose currently serves as the Vice President of Quality for Reprise. Since 2014 Mr. Ichinose was the Head of Quality at Miromatrix. Mr. Ichinose has served in a variety of roles in the medical technology and pharmaceutical industries in the areas of quality assurance and quality control for both small and large companies. Prior to joining Miromatrix, from 2009 to 2014 Mr. Ichinose led the quality organization for Medafor, Inc., a small medical device company that was acquired by BARD in 2013. Prior thereto, Mr. Ichinose held a variety of positions in the field of microbiological testing of sterile medical products and aseptic manufacturing for companies such as MGI PHARMA, Bayer HealthCare and Cardinal Health.

Curtis Carlson

Vice President of Sales and Marketing

Mr. Carlson is the Vice President of Sales & Marketing for Reprise. Mr. Carlson previously served in this role at Miromatrix since August 2013. Prior to Miromatrix, from 1999 through 2013 Mr. Carlson was Director of Sales & Marketing at Travanti Medical, a medical device company that designed and marketed active transdermal devices that was acquired by Teikoku Pharma USA in 2011.

Harrison Malinoff

Senior Director of Manufacturing

Mr. Malinoff serves as the Senior Director of Manufacturing at Reprise.  Prior to joining Reprise, from 2017 through 2019, Mr. Malinoff was Research and Development Manager at Philips, Image Guided Therapy Devices.  From 2016 through  2017 Mr. Malinoff held the position of Project Manager, Quality Assurance at HLT, a clinical stage company developing transcatheter heart valve technologies. From 2003 to 2016, Mr. Malinoff held a variety of research and development positions of increasing responsibility first at Surmodics, and then Lutonix (acquired by BARD) developing and manufacturing drug-coated balloons for the treatment of vascular disease.  Mr. Malinoff holds both an M.B.A. and a B.S. in Materials Science and Engineering from the University of Minnesota – Twin Cities.

Jake Isenburg, Ph.D.

Vice President of Research and Development

Dr. Isenburg has served as the Vice President of Research & Development for Reprise since June 2019. From 2010 through May 2019, Dr. Isenburg was employed at Vascular Solutions, Inc. first as a Senior Biological Development Scientist and, following the company’s acquisition by Teleflex Incorporated, as Director of Scientific Affairs. Previous to Vascular Solutions, from 2007 to 2010, Dr. Isenburg served as a Senior Research Scientist at Vatrix Medical, a start-up medical device company based on his own patented research, with a focus on the diagnosis and treatment of aneurysms. Dr. Isenburg holds a Ph.D. in Bioengineering from Clemson University and a B.S. in Chemical Engineering from Rose-Hulman Institute of Technology.

Amanda Rustad

Controller and Treasurer

Ms. Rustad has served as Controller and Treasurer of Reprise since May 2019. From 2006 through February of 2017, Ms. Rustad was employed at Vascular Solutions, Inc. first as a Staff Accountant and rising to Assistant Controller. Upon the acquisition of Vascular Solutions by Teleflex Incorporated, Ms. Rustad transitioned to a Senior Business Systems Analyst until her departure in May 2019. Prior to Vascular Solutions, from 2005 through 2006, Ms. Rustad worked as a Staff Accountant at LarsonAllen LLP. Ms. Rustad is a certified public accountant.

Heather Kotila

Vice President of Human Resources

Ms. Kotila has served as Vice President of Human Resources at Reprise since May 2019. Ms. Kotila began her career in Human Resources at Vascular Solutions, Inc. in April of 2000. She held positions of increasing responsibility starting as Human Resources Associate and rising to Director of Human Resources at the time of the company’s acquisition by Teleflex Incorporated in 2017.   From March 2017 to May 2019, Ms. Kotila joined Sleep Number Corporation as their Sr. Benefits Analyst. Ms. Kotila holds a PHR certification from the HR Certification Institute.

Board of Directors

Howard Root

Chairman

Mr. Root co-founded Vascular Solutions, Inc. in 1997 and served as its Chief Executive Officer from inception of the company through its sale to Teleflex Incorporated in February 2017 for $1 billion. Under Mr. Root’s leadership, Vascular Solutions developed and commercialized over 100 new medical devices that are used to diagnose and treat a variety of vascular diseases ranging from acute myocardial infarction to varicose veins. After selling Vascular Solutions. in January 2018 Mr. Root co-founded ELUX Marine, Inc., a company engaged in the development and manufacture of an electric powered boat, where he currently serves as Chief Executive Officer. From 1990 to 1995, Mr. Root was employed by ATS Medical, Inc., a mechanical heart valve medical device company, as Vice President and General Counsel. Previous thereto, Mr. Root practiced corporate law at the law firm of Dorsey & Whitney LLP for over five years, specializing in representing emerging growth companies.

Ronald Eibensteiner

Mr. Eibensteiner has been President of Wyncrest Capital, Inc., an investment company for early-stage technology companies in the area of telecommunications, medical devices and software since 1993. He has served on the Board of Directors for Miromatrix since 2010. Mr. Eibensteiner’s past investment activities include: co-founder of Diametrics Medical, Inc., a manufacturer of blood gas diagnostic systems; a principal investor and Board member of OnHealth Network Company, a web-based publisher of health and wellness information which was later merged with WebMD; principal investor and Board member of BigCharts, Inc., a provider of financial internet content, until its sale to Dow Jones/MarketWatch.com in June 1999; Chairman of the Board of Prodea Software Corporation, a data-warehousing software company, until its sale to Platinum Technology, Inc.; and principal investor and Board of Director member of Travanti Pharma Inc, a specialty drug delivery firm, until its sale to Teikoku Pharmaceutical in May of 2009. Mr. Eibensteiner also served as a member of the Board of Stellant Software (Nasdaq: STEL) from 1996 until 2001. In 1983, he co-founded Arden Medical Systems and served as its Chief Financial Officer until its sale to Johnson & Johnson in 1987.

Erwin Kelen

Mr. Kelen has been a full-time venture capitalist and angel investor for the past twenty years. He is the founder of Kelen Ventures, a business development and private investment firm. He is currently a board member of several technology-based companies including: Ready Credit Corporation, Rebiotix Inc, Kwikbit Inc and Healthe. Previously, he was the President and CEO of DataMyte Corporation, a factory automation hardware and software manufacturer. He was also Chairman and CEO of Electro-Craft Corporation, a manufacturer of DC servomotors and controls. Over the past 45 years, Mr. Kelen has served as director of several public and private companies, ranging from early stage development companies to firms listed on the New York Stock Exchange. He is also active in community affairs and serves on the Boards of the University of Minnesota Foundation and the Saint Paul Chamber Orchestra.

Carrie Powers

Ms. Powers has served as President and Chief Executive Officer of Reprise since May 2019. From 2006 through February 2018, Ms. Powers held a succession of positions of increasing responsibility at Vascular Solutions, Inc., starting as Associate Product Manager in 2006 and rising to Senior Vice President of Marketing at the time of the company’s acquisition by Teleflex Incorporated in 2017. Following that acquisition, Ms. Powers continued in management at Teleflex in the role of Senior Director of Clinical & Medical Affairs. From March 2018 to February 2019, Ms. Powers served on the management team of the medical device company CHF Solutions, Inc., first as its Vice President of Marketing and most recently as its Senior Vice President of Commercial Operations. Prior to joining Vascular Solutions, Ms. Powers was employed by St. Mary’s Hospital in Madison, Wisconsin from 2002 to 2006, most recently as a Registered Nurse in the Interventional Cardiac Catheterization Lab.

Jeff Ross, PHD

Dr. Ross has been President and Chief Executive Officer of Miromatrix since February 2017, and previous thereto was Vice President of Product Development of Miromatrix since 2010. From 2008 through 2010, Mr. Ross was Director of Advanced Therapeutics R&D at SurModics, a biomaterials medical device company. Previously, Dr. Ross was a Research Scientist at Athersys, a stem cell technology company, and Guidant, a cardiovascular medical device company. Dr. Ross has more than 20 years of biomedical research, management and regulatory experience in regenerative medicine, biologics, and medical devices, including concept development, preclinical, clinical, manufacturing and commercialization. Dr. Ross has over 30 patents along with scientific publications in Nature and other peer reviewed journals. Dr. Ross holds a Master’s degree in Biomedical Engineering with a focus on tissue engineering and a Ph.D. in Molecular, Cellular and Developmental Biology, both from the University of Minnesota.

Bitnami